Well-Differentiated Ovarian Sertoli-Leydig Cell Tumors

1985 ◽  
Vol 40 (6) ◽  
pp. 376-378
Author(s):  
ROBERT H. YOUNG ◽  
ROBERT E. SCULLY
2007 ◽  
Vol 131 (6) ◽  
pp. 979-981
Author(s):  
Anil Misir ◽  
Monalisa Sur

Abstract Sertoliform endometrioid carcinoma of the ovary (SEC) is an uncommon variant that bears histologic similarity to Sertoli and Sertoli-Leydig cell tumors (SLTs). Clinically, SEC affects an older population (60–70 years), while patients with SLT have an average age of 25 years and may exhibit endocrine manifestations. A number of histologic features can be used to distinguish the 2 entities, the most important ones being (1) the presence of areas with the usual pattern of endometrioid carcinoma, and (2) the presence of mucin at the apical borders of the tumor cells. Cytokeratin stains positively, while inhibin and calretinin stain negatively in SEC; the converse is true for SLTs. Based on the clinicopathologic behavior of this entity, SEC should be considered a well-differentiated carcinoma with relatively good prognosis if limited to the ovary.


Author(s):  
Bozo Kruslin ◽  
Zoran Gatalica ◽  
Ondrej Hes ◽  
Faruk Skenderi ◽  
Markku Miettinen ◽  
...  

1999 ◽  
Vol 161 (5) ◽  
pp. 1571-1572 ◽  
Author(s):  
MARK L. FALLICK ◽  
WILLIAM W. LIN ◽  
LARRY I. LIPSHULTZ

1987 ◽  
Vol 137 (4) ◽  
pp. 747-748 ◽  
Author(s):  
Doug Corrie ◽  
John C. Norbeck ◽  
Ian M. Thompson ◽  
Francisco Rodriguez ◽  
Julius L. Teague ◽  
...  

2000 ◽  
Vol 156 (1) ◽  
pp. 347-353 ◽  
Author(s):  
Keith A. Fowler ◽  
Kiran Gill ◽  
Nameer Kirma ◽  
Dirck L. Dillehay ◽  
Rajeshwar Rao Tekmal

1983 ◽  
Vol 7 (8) ◽  
pp. 755-771 ◽  
Author(s):  
Robert H. Young ◽  
Robert E. Scully

Sign in / Sign up

Export Citation Format

Share Document